Status:
COMPLETED
D-chiro-inositol and Endometrial Thickness
Lead Sponsor:
Lo.Li.Pharma s.r.l
Conditions:
Endometrial Diseases
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.
Eligibility Criteria
Inclusion
- \- altered endometrial thickness
Exclusion
- patients with cancer
- patients under hormonal treatments (progestogens and/or estrogens)
- patients supplemented with inositols
Key Trial Info
Start Date :
March 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT05283642
Start Date
March 8 2022
End Date
December 20 2022
Last Update
December 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ASL Umbria 2
Terni, Umbria, Italy, 05100